Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2007
03/29/2007US20070072267 Transformant having galactose induction system and use thereof
03/29/2007US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog
03/29/2007US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof
03/29/2007US20070072259 Fluorescent protein
03/29/2007US20070072243 Multiplex screening for lysosomal sotrage disorders (lsds)
03/29/2007US20070072234 Protein capable of binding plasticizer
03/29/2007US20070072231 Tumor suppressor gene
03/29/2007US20070072229 Method for isolation, amplification and quantitation of ribonucleic acid
03/29/2007US20070072221 Methods to screen peptide display libraries using minicell display
03/29/2007US20070072194 Global transcription machinery engineering
03/29/2007US20070072183 Topoisomerase hybrids and methods of use
03/29/2007US20070072171 Solid surface for biomolecule delivery and high-throughput assay
03/29/2007US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
03/29/2007US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae
03/29/2007US20070071770 Recombinant MVA virus, and the use thereof
03/29/2007US20070071769 Recombinant MVA virus, and the use thereof
03/29/2007US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology
03/29/2007US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect
03/29/2007US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria
03/29/2007US20070071739 Treatment of bipolar disorder utilizing anti-fungal compositions
03/29/2007US20070071737 Live bacterium preparation containing lactic acid bacterium as active ingredient and food containing lactic acid bacterium
03/29/2007US20070071675 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer
03/29/2007CA2623176A1 Protein a production and purification without using animal derived components
03/29/2007CA2623102A1 Plant extract and use thereof as a cryoprotective agent
03/29/2007CA2622619A1 Method of producing liquid koji having enhanced plant fiber degradation enzyme, liquid koji obtained by the method and use thereof
03/29/2007CA2622542A1 Protein a production and purification without using animal derived components
03/29/2007CA2621328A1 Gene encoding cell wall mannoprotein and use thereof
03/28/2007EP1767644A1 Microbial strains producing sphingosine
03/28/2007EP1767640A1 Process for producing protein a-like protein with use of brevibacillus genus bacaterium
03/28/2007EP1767638A2 Mutation associated with epilepsy
03/28/2007EP1767637A1 Mutation associated with epilepsy
03/28/2007EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
03/28/2007EP1767635A1 Fluorescent protein
03/28/2007EP1767634A1 Novel galectin 8 modification protein and use thereof
03/28/2007EP1767630A1 Apparatus for disrupting cells or viruses using laser and magnetic beads
03/28/2007EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins
03/28/2007EP1767627A1 Anti-perp antibody
03/28/2007EP1767625A1 Activity regulator for interferon producing cell
03/28/2007EP1767624A1 Improved nitrile hydratase
03/28/2007EP1767616A2 Method for producing L-amino acids or ketoacids employing coryneform bacteria with attenuated aceE (pdhA) expression
03/28/2007EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
03/28/2007EP1767103A2 Porphyrin containing lactic acid bacterial cells and use thereof
03/28/2007EP1766601A2 Genetically purified gellan gum
03/28/2007EP1766073A1 Enhancing protein expression
03/28/2007EP1766040A2 Methods for transforming and expression screening of filamentous fungal cells with a dna library
03/28/2007EP1766030A2 Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants
03/28/2007EP1766028A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
03/28/2007EP1766023A2 Metabolically engineered cells for the production of polyunsaturated fatty acids
03/28/2007EP1766007A1 Non-recombinant saccharomyces strains that grow on xylose
03/28/2007EP1765993A2 Truncated st6galnaci polypeptides and nucleic acids
03/28/2007EP1765979A1 Methionine producting microorganism and method of producing l-methionine using the microorganism
03/28/2007EP1765978A2 Methods for production of xylitol in microorganisms
03/28/2007EP1765977A2 Flavonoids
03/28/2007EP1765976A2 Flocculation method and flocculated organism
03/28/2007EP1765975A1 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
03/28/2007EP1765973A1 Device for algae production
03/28/2007EP1765856A2 Rna-dependent dna polymerase from geobacillus stearothermophilus
03/28/2007EP1765854A1 An expression system comprising operably linked rgg gene and gtfg promoter
03/28/2007EP1765418A2 Method for enhancing production of isoprenoid compounds
03/28/2007EP1765061A2 Citrus sudden death
03/28/2007EP1403371B1 Polypeptide having a cell death inhibitory activity
03/28/2007EP1082416B1 Poly(adp-ribose)polymerase gene
03/28/2007EP0815246B1 Methods and compositions for secretion of heterologous polypeptides
03/28/2007CN1938428A Plasmid system for multigene expression
03/28/2007CN1938426A Generation of recombinant genes in saccharomyces cerevisiae
03/28/2007CN1938422A Mutant alpha-amylases
03/28/2007CN1938418A L-glutamic acid-producing microorganism and method for producing L-glutamic acid
03/28/2007CN1938233A Method for treating ammonia-containing wastewater
03/28/2007CN1936012A Method for coustructing shRNA expression carrier for inhibiting N-acetylglucosamine transferase V and its use
03/28/2007CN1936006A Gene of encoding cell wall mannoprotein and use thereof
03/28/2007CN1935993A Compound enzyme preparation, and its preparing method and use
03/28/2007CN1935992A Clean efficient production method for ganoderma lucidum laccase
03/28/2007CN1935991A Clostridium perfringen glycerol dehydrase gene, and its 1,3-propylene glycol producing method
03/28/2007CN1935983A Bacterium producing L-glutamic acid and method for producing L-glutamic acid
03/28/2007CN1935982A Method for separating and purifying acetobacter xylinum from black tea fungus
03/28/2007CN1935981A Method for increasing acid resistance of plant lactobacillus
03/28/2007CN1935980A Method for separating and purifying wine-brewing microzyme from black tea fungus
03/28/2007CN1935979A Coragyceps militaris bacterium culture method
03/28/2007CN1935978A Method for culturing Chinese caterpillar domestic fungus from fresh egg
03/28/2007CN1935977A Levo lactone hydrolase producing fungus, and its method for preparing chiral hydroxy acid
03/28/2007CN1935976A Technological method for rapid producing black tea fungus using pure fungus combination and industrial forced ventilation
03/28/2007CN1935840A Human receptor proteins; related reagents and methods
03/28/2007CN1935706A Brewex's grains waste water treating process
03/28/2007CN1935260A Human antibodies that bind human tnfalpha
03/28/2007CN1934989A Microbial fodder additive
03/28/2007CN1307302C Plasmid DNA large scale purification process
03/28/2007CN1307299C Enriched nematodes and aquaculture method using same
03/28/2007CN1307202C Method for reducing reducing content of sugar in light corn extrcution
03/28/2007CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/27/2007US7196218 Water immiscible solvent mixture containing amines, 91% by volume of isomers of highly branched di-alkyl amines and with very low content of mono-alkyl amines; used for solvent extraction of acetic acid from bioreactor broth; solvent is modified form of tradename Adogen 283 (reg) solvent
03/27/2007US7196189 Comprises modified lovastatin regulatory proteins for use in treatment of hypercholesterolemia
03/27/2007US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies
03/27/2007US7196171 Alstrom syndrome is a homogeneous autosomal recessive disorder characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficiency; isolated polypeptide
03/27/2007US7196168 Metalloprotease-disintegrin ADAM23 (SVPH3-17)
03/27/2007US7195915 Vectors for animal cells and use thereof
03/27/2007US7195907 Non-ribosomal peptide synthetases and associated biosynthetic genes
03/27/2007US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome
03/27/2007US7195904 Preparing hydroxynitrilase for generation of cyanohydrins; disease resistant plants
03/27/2007US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ
03/27/2007US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders